Skip to main content

Table 4 Adverse events

From: Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

Adverse events Grade 1–2 Grade 3–4
Alopecia 88.2% (15/17)  
Neutropenia 64.7% (11/17) 17.6% (3/17)
Fatigue 52.9% (9/17) 11.8% (2/17)
Anemia 47.1% (8/17) 11.8% (2/17)
Nausea 41.2% (7/17) 5.9% (1/17)
Leukopenia 35.3% (6/17) 11.8% (2/17)
Peripheral neuropathy 29.4% (5/17) 5.9% (1/17)
Anorexia 29.4% (5/17)  
Diarrhea 23.5% (4/17) 5.9% (1/17)
Thrombocytopenia 23.5% (4/17) 5.9% (1/17)
Alkaline phosphatase increased 17.6% (3/17)  
Fever 11.8% (2/17)  
Abdominal pain 11.8% (2/17)  
Pneumonitis 5.9% (1/17)  
  1. Data are presented as percentages (number events/total)
\